Oct 31, 2023
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.45 to $0.03.
The split itself did not change the total investment value.
Gyre Therapeutics, Inc. (GYRE) trades on the NASDAQ Capital Market in the Biotechnology industry.
Gyre Therapeutics, Inc. company overviewThe latest split shown was on October 31, 2023. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records 3 reverse splits between August 21, 2015 and October 31, 2023.